Cargando…

The impact of immune disturbances on the failure of antituberculosis treatment

BACKGROUND AND AIM: Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex, with an evolution and treatment outcome determined by the interaction between the mycobacterial and human genotypes. Various deficiencies of innate immune response starting from the first encounte...

Descripción completa

Detalles Bibliográficos
Autores principales:	LESNIC, EVELINA, GHINDA, SERGHEI, POP, CARMEN MONICA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111489/ https://www.ncbi.nlm.nih.gov/pubmed/27857518 http://dx.doi.org/10.15386/cjmed-609

Ejemplares similares

The role of exogenous risk factors of antituberculosis treatment failure
por: LESNIC, EVELINA, et al.
Publicado: (2016)

The impact of diabetes mellitus on the anti-tuberculosis treatment outcome: a series of cases from the Republic of Moldova
por: Lesnic, Evelina, et al.
Publicado: (2021)

Particularities of preimmune reactivity in patients with pulmonary tuberculosis in combination with toxocariasis
por: Smesnoi, Valentina, et al.
Publicado: (2013)

Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment
por: Knight, Marlene, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis
por: Ding, Junjie, et al.
Publicado: (2020)

Empyema Necessitans due to Interruption of Antituberculosis Treatment
por: Benaragama, H. N., et al.
Publicado: (2019)

Adverse drug reaction profile of daily regimen antituberculosis treatment
por: Sankar, K. N. Hari, et al.
Publicado: (2022)

Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment
por: Wang, Jann Yuan, et al.
Publicado: (2015)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
por: Hernandez-Cardenas, CH, et al.
Publicado: (2014)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

Factors affecting successful antituberculosis treatment: a single-center experience
por: Gonçalves, Marcella Cardoso, et al.
Publicado: (2023)

Mycobacterium tuberculosis resistance to antituberculosis drugs in Mozambique,
por: Pires, Germano Manuel, et al.
Publicado: (2014)

Clinical impact of plasma concentrations of first-line antituberculosis drugs
por: Perumal, R, et al.
Publicado: (2023)

Plasma metabolome predicts trained immunity responses after antituberculosis BCG vaccination
por: Koeken, Valerie A. C. M., et al.
Publicado: (2022)

Impact of Non-Alcoholic Simple Fatty Liver Disease on Antituberculosis Drug-Induced Liver Injury
por: Liu, Yi-Hui, et al.
Publicado: (2021)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Association between serum selenium level and conversion of bacteriological tests during antituberculosis treatment
por: de Moraes, Milena Lima, et al.
Publicado: (2014)

Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Epidemiology of tuberculosis and susceptibility to antituberculosis drugs in Reunion Island
por: Loukman, Moreea, et al.
Publicado: (2023)

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence
por: Andreu, Nuria, et al.
Publicado: (2012)

Clinical deterioration during antituberculosis treatment in Africa: Incidence, causes and risk factors
por: Pepper, Dominique J, et al.
Publicado: (2010)

In Vivo and In Vitro Effects of Antituberculosis Treatment on Mycobacterial Interferon-γ T Cell Response
por: Sauzullo, Ilaria, et al.
Publicado: (2009)

Photovoice: A Novel Approach to Improving Antituberculosis Treatment Adherence in Pune, India
por: Shelke, Sangita C., et al.
Publicado: (2014)

Mycobacterium tuberculosis Specific CD8(+) T Cells Rapidly Decline with Antituberculosis Treatment
por: Nyendak, Melissa R., et al.
Publicado: (2013)

Syntheses and evaluation of multicaulin and miltirone-like compounds as antituberculosis agents
por: Burmaoğlu, Serdar, et al.
Publicado: (2017)

A National Department of Public Health in Relation to the Antituberculosis Problem
por: Reed, Charles A. L.
Publicado: (1908)

Current research toward optimizing dosing of first-line antituberculosis treatment
por: McIlleron, Helen, et al.
Publicado: (2018)

Antituberculosis Targeted Drug Delivery as a Potential Future Treatment Approach
por: Mazlan, Mohd Khairul Nizam, et al.
Publicado: (2021)

Barriers to Initiation of Antiretrovirals during Antituberculosis Therapy in Africa
por: Pepper, Dominique J., et al.
Publicado: (2011)

Antituberculosis: Synthesis and Antimycobacterial Activity of Novel Benzimidazole Derivatives
por: Keng Yoon, Yeong, et al.
Publicado: (2013)

The Acceptability of Adherence Support via Mobile Phones for Antituberculosis Treatment in South India: Exploratory Study
por: Jose, Nisha K, et al.
Publicado: (2022)

Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure: A Case Report and Review of the Literature
por: Li, Xiaoyan, et al.
Publicado: (2015)

Five-antituberculosis Drug-resistance Genes Detection Using Array System
por: Shimizu, Yasuo, et al.
Publicado: (2008)

A retrospective study on sequential desensitization-rechallenge for antituberculosis drug allergy
por: Thong, Bernard Yu-Hor, et al.
Publicado: (2014)

Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats
por: Sahu, Nisha, et al.
Publicado: (2019)

The dilemma in a case of immune thrombocytopenia in a patient with human immunodeficiency virus on antituberculosis treatment for miliary pulmonary tuberculosis
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2019)

Variations of Serum Oxidative Stress Biomarkers under First-Line Antituberculosis Treatment: A Pilot Study
por: Meca, Andreea-Daniela, et al.
Publicado: (2021)

The Effect of an Antituberculosis Serum on the Development of Experimental Tuberculosis of the Skin
por: Thomas, Robert M., et al.
Publicado: (1940)

Cannot write session to /tmp/vufind_sessions/sess_dthhfmbha7el36t2dku6juqehb